An open-label dosing study of paroxetine in depressed children and adolescents
- 30 September 2002
- journal article
- Published by Elsevier BV in Current Therapeutic Research
- Vol. 63 (9), 588-601
- https://doi.org/10.1016/s0011-393x(02)80063-7
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating studyJournal of Affective Disorders, 1999
- Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depressionBiological Psychiatry, 1999
- Pharmacological Treatment of Depression in Children and AdolescentsPediatric Drugs, 1999
- Outcome Definitions and Predictors in DepressionPsychotherapy and Psychosomatics, 1998
- ParoxetineDrugs, 1998
- Paroxetine in Children With Major Depressive Disorder: An Open TrialJournal of the American Academy of Child & Adolescent Psychiatry, 1997
- Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorderBiological Psychiatry, 1997
- Childhood and Adolescent Depression: A Review of the Past 10 Years. Part IJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitorPsychopharmacology, 1987